Abstract

BackgroundFormulation of DNA/cationic lipid complexes (lipoplexes) designed for nucleic acid delivery mostly results in positively charged particles which are thought to enter cells by endocytosis. We recently developed a lipoplex formulation called Neutraplex that allows preparation of both cationic and anionic stable complexes with similar lipid content and ultrastructure.Methodology/Principal FindingsTo assess whether the global net charge could influence cell uptake and activity of the transported oligonucleotides (ON), we prepared lipoplexes with positive and negative charges and compared: (i) their physicochemical properties by zeta potential analysis and dynamic light scattering, (ii) their cell uptake by fluorescence microscopy and flow cytometry, and (iii) the biological activity of the transported ON using a splicing correction assay. We show that positively or negatively charged lipoplexes enter cells cells using both temperature-dependent and -independent uptake mechanisms. Specifically, positively charged lipoplexes predominantly use a temperature-dependent transport when cells are incubated OptiMEM medium. Anionic lipoplexes favour an energy-independent transport and show higher ON activity than cationic lipoplexes in presence of serum. However, lipoplexes with high positive global net charge and OptiMEM medium give the highest uptake and ON activity levels.ConclusionsThese findings suggest that, in addition to endocytosis, lipoplexes may enter cell via a temperature-independent mechanism, which could be mediated by lipid mixing. Such characteristics might arise from the specific lipoplex ultrastructure and should be taken into consideration when developing lipoplexes designed for in vivo or ex vivo nucleic acid transfer.

Highlights

  • Non-viral DNA delivery systems have been developed to facilitate gene entry into mammalian cells

  • These findings suggest that, in addition to endocytosis, lipoplexes may enter cell via a temperatureindependent mechanism, which could be mediated by lipid mixing

  • Such characteristics might arise from the specific lipoplex ultrastructure and should be taken into consideration when developing lipoplexes designed for in vivo or ex vivo nucleic acid transfer

Read more

Summary

Introduction

Non-viral DNA delivery systems have been developed to facilitate gene entry into mammalian cells. Among the polycharged vectors currently used, DNA/cationic lipid complexes (lipoplexes) [1] seem promising candidates since they deliver nucleic acids efficiently both in vitro and in vivo [1,2,3,4]. Various systems are commercially available for lipoplexmediated transfection (lipofection) of cultured cells and 7.1% of the current gene therapy clinical trials concern the evaluation of lipoplex formulations to deliver genes, active molecules or drugs (www.wiley.co.uk/genetherapy/clinical/). Plasma proteins with anionic charges may non- bind to positively-charged lipoplexes and rapidly remove them from the circulation via the reticulo-endothelial system [3]. Formulation of DNA/cationic lipid complexes (lipoplexes) designed for nucleic acid delivery mostly results in positively charged particles which are thought to enter cells by endocytosis. We recently developed a lipoplex formulation called Neutraplex that allows preparation of both cationic and anionic stable complexes with similar lipid content and ultrastructure

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call